Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer

• Published in: Nutrition (Burbank, Los Angeles County, Calif.) Vol. 116; p. 112191
• Main Authors: Zhang, Heyang, Shi, Jinyu, Xie, Hailun, Liu, Xiaoyue, Ruan, Guotian, Lin, Shiqi, Ge, Yizhong, Liu, Chenan, Chen, Yue, Zheng, Xin, Song, Mengmeng, Yang, Ming, Zhang, Xiaowei, Shi, Han-Ping
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2023; Elsevier Limited
• Subjects: Age; Albumin; Biomarkers; blood serum; Body mass index; Body size; C-Reactive Protein; calibration; Cancer; Cancer therapies; Cardiovascular disease; Chemotherapy; Correlation analysis; CRP-albumin-lymphocyte (CALLY) index; Diabetes; Diabetes mellitus; dose response; drug therapy; family; Female; females; Gastric cancer; Genetics; Hospitals; Humans; Hypertension; Lymphocytes; Lymphocytes - pathology; Male; males; Medical prognosis; Men; Neoplasm Staging; Nomogram; Nomograms; Nutrition; Patients; prediction; Prediction models; Prognosis; radiotherapy; Random sampling; Regression analysis; Retrospective Studies; risk; Risk factors; Serum albumin; Smoking; Software; Spline functions; Statistical sampling; Stomach Neoplasms; Surgery; Systemic inflammation gastric cancer; Training; Tumors; Womens health; China; Prognosis; Systemic inflammation gastric cancer; CRP-albumin-lymphocyte (CALLY) index; Nomogram

•Patients with gastric cancer and a high C-reactive protein–albumin–lymphocyte (CALLY) index have better overall survival.•The CALLY index could be used as an independent prognostic factor for patients with gastric cancer.•The nomogram combining TNM stage, body mass index, and the CALLY index has be...